WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: VACCINE

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on VACCINE

Proof of use for VACCINE

We do not have any records of a proof of use for VACCINE at this moment.

Click here to add a proof of use for VACCINE

Possible trademark infringements of VACCINE

Basic Information about VACCINE

Serial Number
86730188
Filing Date
19 Aug 2015
Registration Number
5076290
Registration Date
08 Nov 2016
Mark Drawing Code
4

Classifications

Declare the trademark use of VACCINE on the blockchain with WikiTrademarks.io.

First use of VACCINE anywhere
VACCINE was first used on 11 May 2016 for the primary classification of goods and services, international, 003 (Cosmetics and cleaning preparations)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
2
International Code
003
US Codes
001; 004; 006; 050; 051; 052

Who owns VACCINE?

1. Deciem Beauty Group Inc. Toronto, Ontario

2. Deciem Beauty Group Inc. Toronto, Ontario

3. Deciem Beauty Group Inc. Toronto, Ontario

Correspondent

Douglas R. Wolf
Wolf, Greenfield & Sacks, P.C.
600 Atlantic Avenue
Boston MA 02210

Recent News about VACCINE

Other Barks & Bites for Friday, October 18: OpenAI Outlines Defensive Patent Strategy; Microsoft Files Opposition in Lawsuit Alleging Illegal Buyer’s Cartel for Patent Licenses; Moderna Under Fire for Spikevax Vaccine Tech Tweet this

This week on MIP: Fresh UPC decision, COVID vaccine sharing Tweet this

Other Barks & Bites for Friday, August 4: Ted Cruz Proposes Bill to Clarify NCCA NIL Rules; GSK Accuses Pfizer of Infringing on its RSV Vaccine Patent; American Axle Claim Upheld in District Court Tweet this

Other Barks & Bites for Friday, June 9: CAFC Issues Precedential Opinion on Inventorship, USPTO Releases Five-Year Plan, Vaccine Makers Get Hit with Another Patent Infringement Suit Tweet this

Other Barks & Bites for Friday, March 24: Non-DOCX Fee Delayed Further; SCOTUS Petition Says Hirshfeld’s Review of PTAB Decision Violated Federal Vacancies Reform Act; Moderna CEO Grilled by Senate Committee over COVID Vaccine Price Hike Tweet this

Other Barks & Bites for Friday, November 4: CAFC Offers Mixed Bag in Uniloc Appeals, Global Music Copyright Market Valued at Nearly $40 Billion, and Moderna Loses Bid to Have U.S. Government Face Vaccine Patent Claims Tweet this

BIO and Vaccine Manufacturers Group Sign on to Berlin Declaration on Vaccine Access Tweet this

Other Barks and Bites for Friday, October 21: Senators Push Biden to Protect Vaccine IP, Thaler Shot Down Again at CAFC and UPC Confirms 85 Judges Tweet this

Moderna sues Pfizer, BioNTech over COVID-19 mRNA Vaccine Patents Tweet this

Senators Call for Transparency as Global Leaders Call for Action on COVID Vaccine Waiver Talks Tweet this

This week in IP: vaccine waiver compromise agreed, IP intensive industries make 41% US GDP, and more Tweet this

Latest WTO Waiver Compromise Text Targets COVID Vaccine Patents, Draws Criticism from Both Sides Tweet this

SCOTUS, Vaccine Mandates and Patent Law: God Help Us Tweet this

Examining the Moderna-NIH COVID-19 Vaccine Debate in the Context of Bayh-Dole Tweet this

FDA Resists FOIA Request for Vaccine Approval Info as Biden Administration Offers to Share it with the World Tweet this

Black market for fake vaccine cards thrives on Telegram Tweet this

Black market for fake vaccine cards thrives on Telegram Tweet this

Apple Partners TSMC and Foxconn are Scrambling to Find COVID-19 Vaccine Sources and Supply to keep Production Humming Tweet this

Other Barks & Bites for Friday, June 4: EU Plans Alternative to Vaccine Patent Waiver Proposal, CAFC Finds Prosecution Laches as Section 145 Defense for USPTO, and Antitrust Investigations into Facebook Marketplace Launched in EU and UK Tweet this

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on VACCINE